Literature DB >> 17624837

Early evolution of hepatitis C virus (HCV) quasispecies after liver transplant for HCV-related disease.

Evelyne Schvoerer1, Eric Soulier, Cathy Royer, Anne-Catherine Renaudin, Christine Thumann, Samira Fafi-Kremer, Nicolas Brignon, Stephane Doridot, Nicolas Meyer, Patricia Pinson, Bernard Ellero, Marie-Lorraine Woehl-Jaegle, Carole Meyer, Philippe Wolf, Pierre Zachary, Thomas Baumert, Francoise Stoll-Keller.   

Abstract

BACKGROUND: End-stage liver disease as a result of chronic hepatitis C virus (HCV) infection is the main indication for liver transplant (LT), but allografts are systematically infected with HCV soon after transplant. Viral quasispecies are poorly described during the early posttransplant period.
METHODS: For 17 patients who received an LT for HCV disease, plasma viral quasispecies evolution was determined by sequence analysis of hypervariable region 1 of the E2 envelope gene before transplant (BT), after 7 days (D7), and after 1 month (M1). T helper (Th)1/Th2 cytokine levels were determined concomitantly.
RESULTS: HCV quasispecies showed a significant decrease in amino acid diversity at D7 and M1, compared with BT (P<.05). A correlation was observed between low plasma tumor necrosis factor-alpha levels at D7 and decreased quasispecies amino acid complexity at the same date. Nucleic acid diversity was lower for genotype 1 than for genotype 3 infection (P<.05). The complexity and diversity of amino acids were lower in patients with hepatocellular carcinoma (HCC) BT than in those without HCC (P<.05). Conserved amino acid residues within quasispecies were shared by the whole cohort before and after LT.
CONCLUSION: Viral structural and/or host immunological features could favor the emergence of fitter HCV strains after LT.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17624837     DOI: 10.1086/519691

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  7 in total

1.  Unexpected maintenance of hepatitis C viral diversity following liver transplantation.

Authors:  Rebecca R Gray; Samantha L Strickland; Nazle M Veras; Maureen M Goodenow; Oliver G Pybus; Stanley M Lemon; Michael W Fried; David R Nelson; Marco Salemi
Journal:  J Virol       Date:  2012-05-23       Impact factor: 5.103

2.  HCV in liver transplantation.

Authors:  Giacomo Germani; Emmanuel Tsochatzis; Vasilios Papastergiou; Andrew K Burroughs
Journal:  Semin Immunopathol       Date:  2012-07-25       Impact factor: 9.623

Review 3.  The quasispecies nature and biological implications of the hepatitis C virus.

Authors:  Sarah L Fishman; Andrea D Branch
Journal:  Infect Genet Evol       Date:  2009-08-08       Impact factor: 3.342

Review 4.  NK cells, innate immunity and hepatitis C infection after liver transplantation.

Authors:  Anoma Nellore; Jay A Fishman
Journal:  Clin Infect Dis       Date:  2011-02-01       Impact factor: 9.079

5.  Antiviral treatment for hepatitis C virus infection after liver transplantation.

Authors:  Yasuhiko Sugawara; Sumihito Tamura; Norihiro Kokudo
Journal:  Hepat Res Treat       Date:  2010-11-01

6.  Viral entry and escape from antibody-mediated neutralization influence hepatitis C virus reinfection in liver transplantation.

Authors:  Samira Fafi-Kremer; Isabel Fofana; Eric Soulier; Patric Carolla; Philip Meuleman; Geert Leroux-Roels; Arvind H Patel; François-Loïc Cosset; Patrick Pessaux; Michel Doffoël; Philippe Wolf; Françoise Stoll-Keller; Thomas F Baumert
Journal:  J Exp Med       Date:  2010-08-16       Impact factor: 14.307

Review 7.  Neutralizing antibodies and pathogenesis of hepatitis C virus infection.

Authors:  Samira Fafi-Kremer; Catherine Fauvelle; Daniel J Felmlee; Mirjam B Zeisel; Quentin Lepiller; Isabel Fofana; Laura Heydmann; Françoise Stoll-Keller; Thomas F Baumert
Journal:  Viruses       Date:  2012-10-09       Impact factor: 5.048

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.